One of the Chinese drug companies I’ve been following for almost a year is Sinobiopharma, Inc. (OTC:SNBP).
by J. Christoph Amberger
Baltimore, MD: Last June, in a small ceremony in Guangzhou, China, U.S. and Chinese officials signed three agreements that will change the face of the global pharma industry. At face value, it was the most boring
read more..
It’s Keynesian economics at its finest: Govenment CAN spend a sector out of a slump… as long as it keeps paying people to spend! Could home builders like Beazer Homes (NYSE:BZH) and Hovnanian Enterprises (NYSE:HOV) be rising on anticipated subsidies?
By J. Christoph Amberger
Baltimore, MD: Let’s hear it for government spending the economy out of recession!
Sales of
read more..
Pharma companies MannKind (NASDAQ:MNKD), Roche Holding (OTC:RHHBY), and Acorda Therapeutics (NASDAQ:ACOR) have seen stock price moves on FDA news. Will the magic work for Spectrum Pharmaceuticals (NASDAQ:SPPI) on January 30?
by J. Christoph Amberger
Baltimore, MD: On Dec. 30, TFN posted a list of upcoming FDA announcement dates: Upcoming FDA decision dates… and the companies that may benefit.
As you
read more..
The Dow’s experienced the steepest drop since Feb. 2009. What lies ahead?
by J. Christoph Amberger
Baltimore, MD: The weeks started on such a promising note I was fantasizing about a Dow 11,000, giddy at the prospects that Brown would do for you what he did for re-establishing a semblance of balance of power in the United
read more..
The list reads like wind chills in Chicago on a cold winter day: Coeur d’Alene Mines Corporation (NYSE:CDE), Silver Wheaton Corp. (NYSE:SLW), Alto Group Holdings Inc. (OTC:ALTO), Hecla Mining Company (NYSE:HL), Endeavour Silver Corp. (AMEX:EXK) all close down dramatically for a second day. What to do now?
by J. Christoph Amberger
Baltimore, MD: The price decline in
read more..
One of the Chinese drug companies I’ve been following for almost a year is Sinobiopharma, Inc. (OTC:SNBP).
by J. Christoph Amberger
Baltimore, MD: Last June, in a small ceremony in Guangzhou, China, U.S. and Chinese officials signed three agreements that will change the face of the global pharma industry. At face value, it was the most boring
read more..
It’s Keynesian economics at its finest: Govenment CAN spend a sector out of a slump… as long as it keeps paying people to spend! Could home builders like Beazer Homes (NYSE:BZH) and Hovnanian Enterprises (NYSE:HOV) be rising on anticipated subsidies?
By J. Christoph Amberger
Baltimore, MD: Let’s hear it for government spending the economy out of recession!
Sales of
read more..
Pharma companies MannKind (NASDAQ:MNKD), Roche Holding (OTC:RHHBY), and Acorda Therapeutics (NASDAQ:ACOR) have seen stock price moves on FDA news. Will the magic work for Spectrum Pharmaceuticals (NASDAQ:SPPI) on January 30?
by J. Christoph Amberger
Baltimore, MD: On Dec. 30, TFN posted a list of upcoming FDA announcement dates: Upcoming FDA decision dates… and the companies that may benefit.
As you
read more..
The Dow’s experienced the steepest drop since Feb. 2009. What lies ahead?
by J. Christoph Amberger
Baltimore, MD: The weeks started on such a promising note I was fantasizing about a Dow 11,000, giddy at the prospects that Brown would do for you what he did for re-establishing a semblance of balance of power in the United
read more..
The list reads like wind chills in Chicago on a cold winter day: Coeur d’Alene Mines Corporation (NYSE:CDE), Silver Wheaton Corp. (NYSE:SLW), Alto Group Holdings Inc. (OTC:ALTO), Hecla Mining Company (NYSE:HL), Endeavour Silver Corp. (AMEX:EXK) all close down dramatically for a second day. What to do now?
by J. Christoph Amberger
Baltimore, MD: The price decline in
read more..
COPYRIGHT BY Financial Aggregator DESIGNED BY IWEBIX
Powered by Yahoo! Answers